Skip to content

AtriCure ATRC Free cash flow yield

Free cash flow yield at other companies

Abbott logo
AbbottABT
4.1%+1.2pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
3%-2.1pp
Boston Scientific logo
Boston ScientificBSX
3.7%+1.7pp
Medtronic logo
MedtronicMDT
5.2%+0.4pp
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
-3.8%0.0pp
Artivion logo
ArtivionAORT
-0%-1.1pp

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Calculated from AtriCure’s reported figures.

Based on trailing twelve months.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's free cash flow yield?
AtriCure (ATRC) reported free cash flow yield of 3.8% in Q1 2026.
What is the long-term trend for AtriCure's free cash flow yield?
Over 2 years (2021 to 2025), AtriCure's free cash flow yield has grown at a 82.5% compound annual growth rate (CAGR), from -0.7% to 2.5%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.